                         SEQUENCE LISTING

<110>  Fusion Antibodies Limited
       GORMLEY, Julie
       HEGARTY, Shauna
       OLWILL, Shane
 
<120>  Prognostic marker

<130>  P114920.WO.01

<150>  GB 0922553.3
<151>  2009-12-23

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  114
<212>  PRT
<213>  Mus musculus

<400>  1

Val Gln Leu Gln Glu Ser Gly Gly Val Leu Val Lys Pro Gly Gly Ser 
1               5                   10                  15      


Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe Ser Ser Tyr Asp 
            20                  25                  30          


Met Ser Trp Val Arg Gln Thr Pro Glu Lys Arg Leu Glu Trp Val Ala 
        35                  40                  45              


Tyr Ile Thr Thr Gly Gly Val Asn Thr Tyr Tyr Pro Asp Thr Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Ser Ser Leu Lys Ser Glu Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Arg His Ser Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr Val Thr Val 
            100                 105                 110         


Ser Ser 
        


<210>  2
<211>  113
<212>  PRT
<213>  Mus musculus

<400>  2

Asp Val Leu Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val His Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys Ser Gln Thr 
                85                  90                  95      


Thr His Val Pro Pro Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210>  3
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  3

Glu Leu Pro Tyr Gly Arg Glu Asp Val Leu Lys Glu Ala Val Ala Asn 
1               5                   10                  15      


Lys Gly Pro Val Ser Val Gly Val Asp Ala Arg His Pro 
            20                  25                  


